Page last updated: 2024-08-24

clinafloxacin and Pyrexia

clinafloxacin has been researched along with Pyrexia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L	1

Trials

1 trial(s) available for clinafloxacin and Pyrexia

Article	Year
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:1 Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin	2002

Article

Year

Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:1

Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin

2002